Microgestin 1.5/30 Kit
Product Images NDC 75907-083

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Microgestin 1.5/30 (NDC 75907-083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy�s Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Carton (Carton)
The image shows the packaging label for Microgestin 1.5/30 Kit by Dr. Reddy's Laboratories Inc. The kit contains Norethindrone Acetate and Ethinyl Estradiol tablets, USP. Each yellow tablet includes 1.5 mg norethindrone acetate and 0.03 mg ethinyl estradiol. The package contains 6 blister cards of 21 tablets each, with usage and storage instructions, warnings, and barcodes visible.*
FDA Label Image

Table1 (Table1)

Table1 (Table1)
A data table titled 'Lowest Expected and Typical Failure Rates During the First Year of Continuous Use of a Method' showing percentages of women experiencing unintended pregnancy using various contraceptive methods. The table compares 'Lowest Expected' and 'Typical' failure rates across methods like oral contraceptives, diaphragm, spermicides, vaginal sponge, implants, injections, IUDs, condoms, cervical cap, abstinence, withdrawal, and sterilization.*
FDA Label Image

Table2 (Table2)

Table2 (Table2)
A bar chart titled 'Circulatory Disease Mortality Rates Per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' It compares mortality rates for age groups 15-24, 25-34, 35-44, and 45+ among ever-users and controls, divided by smoking status (non-smokers and smokers). The chart shows mortality rates increasing with age and higher rates in smokers compared to non-smokers.*
FDA Label Image

Table3 (Table3)

Table3 (Table3)
A data table titled 'Annual Number of Birth-Related or Method-Related Deaths Associated with Control of Fertility per 100,000 Nonsterile Women by Fertility Control Method According to Age.' The table lists methods of fertility control such as no contraception, oral contraceptives (non-smoker and smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence across age groups from 15-19 to 40-44 with corresponding death rates, distinguishing birth-related from method-related deaths.*
FDA Label Image

Annual Number (Annual Number)

Annual Number (Annual Number)
A data table showing the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age group. The table compares outcomes for methods including no fertility control, oral contraceptives for smokers and non-smokers, IUD, condom, diaphragm/spermicide, and periodic abstinence across age ranges 15-19 to 40-44 years. Footnotes indicate death attribution as birth or method related.*
FDA Label Image

Figure 2 (Figu2)

Figure 2 (Figu2)
An instructional diagram for Microgestin 1.5/30 kit pills, showing a hand placing a day label sticker with days of the week to align with the pill pack. The pill pack is divided into three weeks of yellow (active) pills, arranged in a left-to-right direction. The diagram guides users to start Sunday or Day 1 starters and instructs on the direction to take the pills each week.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A forest plot showing effect estimates from multiple studies comparing contraceptive use and never-use. The horizontal axis represents effect estimates from -1.50 to 2.00. Studies include NICHD Women's Care Study, French E3N cohort, Shanghai Women's Health Study, Nurses' Health Study II, Oxford Family Planning Study, and Danish Sex Hormone Register Study. The graph features odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals.*
FDA Label Image

1 (Image 01)

1 (Image 01)
Chemical structures of the active ingredients Norethindrone Acetate and Ethinyl Estradiol are shown. The diagram depicts the molecular framework of each compound with labeled functional groups.*
FDA Label Image

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.